Towards new combination therapies for the treatment of chronic lymphocytic leukemia
2 Views
administrator
07/08/23
At the 20th Congress of the European Hematology Association (EHA), Paolo Ghia, MD, PhD, of Università Vita-Salute San Raffaele, Milan, Italy, discusses the development of new and more effective therapies, which are focusing on anti-CD20 monoclonal antibody-containing regimens, for the treatment of patients with chronic lymphocytic leukemia.
-
Category
Show more
Facebook Comments
No comments found